Akèy › Maladi Dijestif › Tennessee › Nashville
Etid klinik pou Maladi Dijestif nan Nashville, TN
5 etid pou Maladi Dijestif ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Ap rekriteFaz 3
- 89bio Clinical Study Site, Nashville
- 89bio Clinical Study Site, Hermitage · 9 mi lwen
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Ap rekriteFaz 3
- 89bio Clinical Study Site, Nashville
- 89bio Clinical Study Site, Hermitage · 9 mi lwen
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
Ap rekriteFaz 3
- Vanderbilt University Medical Center, Nashville
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Ap rekriteFaz 3
- Henry-Joyce Cancer Clinic, Nashville
Product Surveillance Registry
Ap rekriteEtid obsèvasyon
- Nashville, Nashville
Etid Maladi Dijestif nan lòt vil
- Houston, TX8 etid
- Chicago, IL8 etid
- New York City, NY8 etid
- Washington, DC6 etid
- San Diego, CA6 etid
- Durham, NC6 etid
- Boston, MA6 etid
- Louisville, KY5 etid
- San Antonio, TX5 etid
- Rochester, MN5 etid
- Tyler, TX5 etid
- Cincinnati, OH5 etid
Lòt etid nan Nashville
- Kansè Poumon ki pa ti selil97 etid
- Kansè nan tete81 etid
- Kansè Metastatik70 etid
- Kansè kolorektal69 etid
- Kansè (tout kalite)65 etid
- Kansè ovè49 etid
- Kansè pwostat43 etid
- Kansè poumon40 etid
- Karsinòm selil skuamèz tèt ak kou39 etid
- Kansè pankreyas39 etid
- Kansè Endomèt38 etid
- Melanom33 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.